Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Avonex Manufacturing Update: New Liquid Fill-Finish Process Validated

This article was originally published in The Pink Sheet Daily

Executive Summary

Biogen Idec has completed validation of a new fill-finish process for the liquid formulation of Avonex.

You may also be interested in...

Biogen Idec Doubling Multiple Sclerosis Sales Force For Antegren Launch

The company will have almost 200 MS sales reps by the time Antegren is expected to launch in early 2005. Partner Elan also will contribute specialty reps for the hospital outpatient setting. Biogen Idec's pre-launch efforts are focusing on reimbursement and neurologists' capacities for I.V. administration.

Biogen Idec Advises Use Of Avonex Powder Formulation To Prevent Shortage

An April 29 Dear Health Care Professional letter says Biogen Idec “may experience” a shortage of the liquid formulation of the MS therapy due to manufacturing impurity issues.

Biogen Addressing Avonex Liquid Formulation Manufacturing Problems

Pre-filled syringe process is experiencing a "technical issue" on the fill-finish side. Biogen has the option to ramp up production of Avonex' original lyophilized powder formulation to make up for shortages on the liquid side.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts